MRNA - Moderna, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - MRNA (1682852)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
36 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-02-24
MRNAHoge StephenPresS - Sale$18.67-10,0002,060,6460%-$186,700
2020-02-21
MRNAZaks Tal ZviChief Medical OfficerS - Sale$18.47-10,00094,770-10%-$184,700
M
2020-02-20
MRNABancel StephaneCEOS - Sale$18.39-16,3327,456,9860%-$300,289
2020-02-14
MRNASagan PaulDirP - Purchase$19.00+52,631514,060+11%+$999,989
2020-02-14
MRNABancel StephaneCEOS - Sale$19.02-11,04624,659,4200%-$210,095
M
2020-02-12
MRNAHoge StephenPresS - Sale$19.34-10,0002,070,6460%-$193,350
2020-02-07
MRNAKim Lorence H.CFOS - Sale$23.06-33,2951,302,510-2%-$767,783
M
2020-02-07
MRNABancel StephaneCEOS - Sale$22.65-33,13415,968,4630%-$750,582
2020-02-03
MRNABancel StephaneCEOS - Sale$20.66-4,87616,744,1350%-$100,738
2020-01-31
MRNABancel StephaneCEOS - Sale$20.43-11,04624,713,4760%-$225,633
M
2020-01-27
MRNAKim Lorence H.CFOS - Sale$23.02-24,7051,335,805-2%-$568,786
M
2020-01-23
MRNAHoge StephenPresS - Sale$21.61-10,0002,080,6460%-$216,073
2020-01-24
MRNABancel StephaneCEOS - Sale$21.22-11,04624,724,5220%-$234,396
2020-01-22
MRNAKim Lorence H.CFOS - Sale$23.04-2,0001,360,5100%-$46,080
2020-01-22
MRNABancel StephaneCEOS - Sale$23.00-15,39824,735,5680%-$354,154
2020-01-21
MRNABancel StephaneCEOS - Sale$20.79-4,85016,784,0630%-$100,832
2020-01-17
MRNABancel StephaneCEOS - Sale$20.96-11,04624,755,8160%-$231,524
2020-01-13
MRNAHoge StephenPresS - Sale$19.14-10,0002,090,6460%-$191,400
2020-01-10
MRNABancel StephaneCEOS - Sale$20.24-16,48216,007,1950%-$333,582
M
2020-01-10
MRNAKania Edwin M Jr10%S - Sale$20.26-475,00023,847-95%-$9,623,813
M
2020-01-02
MRNABancel StephaneCEOS - Sale$19.21-16,1607,568,8740%-$310,397
2019-12-27
MRNABancel StephaneCEOS - Sale$19.53-11,04624,804,4930%-$215,728
2019-12-20
MRNABancel StephaneCEOS - Sale$19.69-11,04624,815,5390%-$217,496
2019-12-12
MRNAZaks Tal ZviChief Medical OfficerS - Sale$18.54-100,000104,770-49%-$1,854,000
2019-12-13
MRNABancel StephaneCEOS - Sale$18.53-11,04624,826,5850%-$204,682
2019-12-10
MRNAKania Edwin M Jr10%S - Sale$18.81-100,000498,847-17%-$1,880,840
M
2019-12-09
MRNAFlagship Ventures Fund IV General Partner LLCDir, 10%S - Sale$18.81-435,85520,253,972-2%-$8,196,936
D
2019-12-06
MRNAKim Lorence H.CFOS - Sale+OE$20.00-238,5321,362,510-15%-$4,770,190
2019-12-06
MRNABancel StephaneCEOS - Sale$20.01-11,04624,795,4990%-$221,081
2019-11-29
MRNABancel StephaneCEOS - Sale$20.54-11,04624,806,5450%-$226,885
2019-11-22
MRNABancel StephaneCEOS - Sale$20.48-11,04624,817,5910%-$226,222
D
2019-11-20
MRNAHutt Peter BartonDirS - Sale+OE$20.18-200,0003,924-98%-$4,036,000
2019-11-15
MRNABancel StephaneCEOS - Sale$19.03-11,04624,828,6370%-$210,216
2019-11-08
MRNABancel StephaneCEOS - Sale$17.38-11,04624,828,6830%-$191,979
2019-11-01
MRNABancel StephaneCEOS - Sale$16.08-11,04624,850,7290%-$177,570
D
2019-09-17
MRNAHutt Peter BartonDirS - Sale+OE$17.63-100,0003,924-96%-$1,763,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top